ZymoGenetics Claims Competitor's Product Poses Serious Patient Safety Issue
This article was originally published in The Pink Sheet Daily
Executive Summary
As it tries to build market share for Recothrom, ZymoGenetics files Citizen's Petition asking FDA to remove its top competitor from the market.